A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.
Tsaur I, Heidegger I, Bektic J, Kafka M, van den Bergh RCN, Hunting JCB, Thomas A, Brandt MP, Höfner T, Debedde E, Thibault C, Ermacora P, Zattoni F, Foti S, Kretschmer A, Ploussard G, Rodler S, von Amsberg G, Tilki D, Surcel C, Rosenzweig B, Gadot M, Gandaglia G, Dotzauer R; EAU-YAU Prostate Cancer Working Party.
Tsaur I, et al. Among authors: hunting jcb.
Cancer Med. 2021 Sep;10(18):6354-6364. doi: 10.1002/cam4.4184. Epub 2021 Aug 10.
Cancer Med. 2021.
PMID: 34374489
Free PMC article.